| dc.contributor.author | Hakki, Shilpa Anand | |
| dc.date.accessioned | 2020-12-17T04:36:26Z | |
| dc.date.available | 2020-12-17T04:36:26Z | |
| dc.date.issued | 2018-05 | |
| dc.identifier.citation | Journal of Evidence Based Medicine and Healthcare. 2018 May; 5(21): 1660-1663. | en_US |
| dc.identifier.issn | 2349-2562 | |
| dc.identifier.uri | http://localhost/xmlui/handle/123456789/1520 | |
| dc.language.iso | en | en_US |
| dc.publisher | Level Up Business Center | en_US |
| dc.subject | Nephrotic syndrome-chemically induced | |
| dc.subject | Nephritis, interstitial | |
| dc.subject | Necrosis-chemically induced | |
| dc.subject | Hyperkalemia-chemically induced | |
| dc.subject | Glomerular filtration rate | |
| dc.subject | Anti-inflammatory agents, non-steroidal | |
| dc.title | NSAID induced nephropathy | en_US |
| dc.type | Article | en_US |